Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin

Xiaoyu Liu1, Huijie Xiao1, Yong Yao1

  • 1Department of Pediatrics, Peking University First Hospital, Beijing, China.

Frontiers in Pediatrics
|January 27, 2023
PubMed

Insights

CblC deficiency, a cobalamin metabolic disorder, often presents with kidney issues like hematuria and proteinuria in children. Early diagnosis and hydroxocobalamin treatment can improve renal and hematological symptoms.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Nephrology

Background:

  • CblC deficiency is the most common inherited disorder of cobalamin metabolism.
  • Pathogenic variants in the MMACHC gene cause CblC deficiency.
  • Renal complications are infrequently reported in CblC deficiency.

Purpose of the Study:

  • To delineate the renal phenotype and genetic characteristics of Chinese children with CblC deficiency.
  • To investigate the clinical presentation and outcomes of renal involvement in CblC deficiency.

Main Methods:

  • Retrospective review of clinical, renal pathological, and genetic data.
  • Inclusion of seven Chinese children diagnosed with CblC deficiency and kidney damage.
  • Analysis of laboratory findings, renal biopsy results, and treatment responses.

Main Results:

  • Seven children with CblC deficiency presented with hematuria, proteinuria, and macrocytic anemia.
  • Renal biopsy in five patients revealed thrombotic microangiopathy.
  • Treatment with hydroxocobalamin improved hematological and renal parameters in most patients, though some progressed to chronic kidney disease.

Conclusions:

  • The MMACHC variant c.80A>G may be linked to significant renal complications in Chinese CblC patients.
  • Macrocytic anemia and hyperhomocysteinemia are key indicators for CblC-related kidney disease.
  • Prompt diagnosis and treatment are crucial for better renal and hematological outcomes in CblC deficiency.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
57
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
25
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
220
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
15
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
53